| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,846 |
15,552 |
$1.38M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
3,227 |
2,879 |
$1.08M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,271 |
5,172 |
$311K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,251 |
2,937 |
$254K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,443 |
2,144 |
$150K |
| 87581 |
|
3,374 |
3,016 |
$145K |
| 87486 |
|
3,371 |
3,013 |
$144K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,624 |
2,307 |
$114K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,108 |
2,646 |
$106K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,531 |
5,832 |
$105K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,125 |
1,955 |
$90K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,783 |
1,613 |
$87K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
3,631 |
3,236 |
$48K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,579 |
1,398 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,368 |
2,102 |
$36K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,482 |
1,352 |
$35K |
| 90686 |
|
1,083 |
796 |
$20K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
297 |
254 |
$19K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,788 |
4,537 |
$12K |
| 99253 |
|
230 |
213 |
$10K |
| 99384 |
|
95 |
94 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
169 |
165 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
103 |
103 |
$9K |
| 82962 |
|
4,397 |
3,074 |
$8K |
| 20610 |
|
250 |
170 |
$8K |
| 99385 |
|
86 |
78 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
298 |
273 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
90 |
86 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,628 |
3,761 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,157 |
812 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
474 |
326 |
$6K |
| 99401 |
|
177 |
82 |
$5K |
| 90674 |
|
238 |
150 |
$5K |
| 99383 |
|
50 |
50 |
$5K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
17 |
15 |
$4K |
| 0013A |
|
108 |
86 |
$4K |
| 0011A |
|
99 |
86 |
$4K |
| 0012A |
|
80 |
75 |
$3K |
| 81003 |
|
1,582 |
1,362 |
$3K |
| 90688 |
|
219 |
153 |
$3K |
| 96127 |
|
263 |
223 |
$3K |
| 86328 |
|
59 |
48 |
$3K |
| 99421 |
|
210 |
199 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
317 |
244 |
$2K |
| 99215 |
Prolong outpt/office vis |
26 |
24 |
$2K |
| 99386 |
|
19 |
14 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
21 |
21 |
$2K |
| 93000 |
|
76 |
72 |
$1K |
| 94760 |
|
573 |
420 |
$1K |
| 99223 |
Prolong inpt eval add15 m |
54 |
49 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
30 |
30 |
$1K |
| 99173 |
|
140 |
139 |
$1K |
| 81025 |
|
210 |
197 |
$1K |
| 99305 |
|
33 |
33 |
$836.04 |
| 91322 |
|
17 |
15 |
$540.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
798 |
601 |
$499.12 |
| 96136 |
|
18 |
18 |
$488.70 |
| 90714 |
|
19 |
16 |
$464.43 |
| 86580 |
|
80 |
61 |
$456.71 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
23 |
21 |
$429.98 |
| 99441 |
|
142 |
139 |
$417.88 |
| 90480 |
|
14 |
14 |
$407.39 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$401.60 |
| G0008 |
Administration of influenza virus vaccine |
43 |
33 |
$376.82 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
23 |
17 |
$359.95 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
760 |
498 |
$319.50 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
139 |
107 |
$187.62 |
| 36415 |
Collection of venous blood by venipuncture |
1,014 |
781 |
$132.06 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
92 |
63 |
$128.53 |
| 99072 |
|
139 |
89 |
$50.00 |
| 99406 |
|
13 |
12 |
$37.50 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
51 |
37 |
$35.82 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
20 |
13 |
$2.50 |